The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Trushina O.V.

Sechenov First Moscow State Medical University

Bykova A.A.

Sechenov First Moscow State Medical University

Malinovskaya L.K.

Sechenov First Moscow State Medical University

Dumikian A.Sh.

Sechenov First Moscow State Medical University

Chomakhidze P.Sh.

Sechenov First Moscow State Medical University

Shaltaeva Yu.R.

National Research Nuclear University MEPhI, Moscow, Russia

Belyakov V.V.

National Research Nuclear University MEPhI, Moscow, Russia

Golovin A.V.

National Research Nuclear University MEPhI, Moscow, Russia

Pershenkov V.S.

National Research Nuclear University MEPhI, Moscow, Russia

Syrkin A.L.

Sechenov First Moscow State Medical University

Betelin V.B.

Scientific Research Institute for System Analysis of the Russian Academy of Sciences, Moscow, Russia

Kopylov F.Yu.

Sechenov First Moscow State Medical University

The role of trimethylamine N-oxide in progression of cardiovascular diseases

Authors:

Trushina O.V., Bykova A.A., Malinovskaya L.K., Dumikian A.Sh., Chomakhidze P.Sh., Shaltaeva Yu.R., Belyakov V.V., Golovin A.V., Pershenkov V.S., Syrkin A.L., Betelin V.B., Kopylov F.Yu.

More about the authors

Read: 5069 times


To cite this article:

Trushina OV, Bykova AA, Malinovskaya LK, et al. The role of trimethylamine N-oxide in progression of cardiovascular diseases. Russian Journal of Cardiology and Cardiovascular Surgery. 2018;11(6):33‑37. (In Russ.)
https://doi.org/10.17116/kardio20181106133

Recommended articles:
Difficulties in differential diagnosis of pulmonary dissemination. Journal of Respiratory Medi­cine. 2025;(2):79-82
Features of care of patients with cardiovascular diseases and cognitive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):99-104
Myokines — the cardiometabolic risk pote­ntial biomarkers. Russian Journal of Preventive Medi­cine. 2025;(7):119-126
Chro­nic kidney disease and microcirculation diso­rders. Russian Journal of Preventive Medi­cine. 2025;(8):123-130
Economics of hype­rparathyroidism. Part 2 — seco­ndary hype­rparathyroidism. Medi­cal Technologies. Asse­ssment and Choice. 2025;(3):74-82

References:

  1. Tang WHW, Hazen SL, Tang W, Hazen S. The contributory role of gut microbiota in cardiovascular disease. Journal of Clinical Investigation. 2014;124(10):4204-4211. https://doi.org/10.1172/JCI72331
  2. Andraws R, Berger JS, Brown DL. Effects of antibiotic therapy on outcomes of patients with coronary artery disease a metaanalysis of randomized controlled trials. JAMA. 2005;293(21):2641. https://doi.org/10.1001/jama.293.21.2641
  3. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, DuGar B, Feldstein AE, Britt EB, Fu X, Chung Y-M, Wu Y, Schauer Ph, Smith JD, Allayee H, Tang WHW, DiDonato JA, Lusis AJ, Hazen SL. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57-63. https://doi.org/10.1038/nature09922
  4. Chhibber-Goel J, Gaur A, Singhal V, Parakh N, Bhargava B, Sharma A. The complex metabolism of trimethylamine in humans: endogenous and exogenous sources. Expert Reviews in Molecular Medicine. 2016;18:e8:1 of 11. https://doi.org/10.1017/erm.2016.6
  5. Kenyon S, Carmichael P, Khalaque S, Panchal S, Waring R, Harris R, Smith RL, Mitchell S. The passage of trimethylamine across rat and human skin. Food and Chemical Toxicology. 2004;42(10):1619-1628. https://doi.org/10.1016/j.fct.2004.05.007
  6. Tang WHW, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. New England Journal of Medicine. 2013;368(17):1575-1584. https://doi.org/10.1056/nejmoa1109400
  7. Tang WHW, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, Li XS, Levison BS, Hazen SL. Gut Microbiota-Dependent Trimethylamine N-Oxide (TMAO) Pathway Contributes to Both Development of Renal Insufficiency and Mortality Risk in Chronic Kidney Disease. Circulation Research. 2014;116(3):448-455. https://doi.org/10.1161/circresaha.116.305360
  8. Schneider J, Girreser U, Havemeyer A, Bittner F, Clement B. Detoxification of Trimethylamine N-Oxide by the Mitochondrial Amidoxime Reducing Component mARC. Chemical Research in Toxicology. 2018;31(6):447-453. https://doi.org/10.1021/acs.chemrestox.7b00329
  9. Veeravalli S, Karu K, Scott F, Fennema D, Phillips IR, Shephard EA. Effect of Flavin-Containing Monooxygenase Genotype, Mouse Strain, and Gender on Trimethylamine N-oxide Production, Plasma Cholesterol Concentration, and an Index of Atherosclerosis. Drug Metabolism and Disposition. 2017;46(1):20-25. https://doi.org/10.1124/dmd.117.077636
  10. Humbert J, Hammond K, Hathaway W, Marcoux J, O’Brien D. Trimethylaminuria: the fish-odour syndrome. The Lancet. 1970;296(7676):770-771. https://doi.org/10.1016/s0140-6736(70)90241-2
  11. Huang F, Zhang F, Xu D, Zhang Z, Xu F, Tao X, Qiu L, Wei H. Enterococcus faecium WEFA23 from infants lessens high-fat-diet-induced hyperlipidemia via cholesterol 7-alpha-hydroxylase gene by altering the composition of gut microbiota in rats. Journal of Dairy Science. 2018;101(9):7757-7767. https://doi.org/10.3168/jds.2017-13713
  12. Bu J, Wang Z. Cross-Talk between Gut Microbiota and Heart via the Routes of Metabolite and Immunity. Gastroenterology Research and Practice. 2018;1-8. https://doi.org/10.1155/2018/6458094
  13. Seldin MM, Meng Y, Qi H, Zhu W, Wang Z, Hazen SL, Lusis AJ, Shih DM. Trimethylamine N‐Oxide Promotes Vascular Inflammation Through Signaling of Mitogen‐Activated Protein Kinase and Nuclear Factor‐κB. Journal of the American Heart Association. 2016;5(2):e002767. https://doi.org/10.1161/jaha.115.002767
  14. Zhu W, Gregory JC, Org E, Buffa JA, Gupta N, Wang Z, Li L, Fu X, Wu Y, Mehrabian M, Sartor RB, McIntyre TM, Silverstein RL, Tang WHW, DiDonato JA, Brown JM, Lusis AJ, Hazen SL. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk. Cell. 2016;165(1):111-124. https://doi.org/10.1016/j.cell.2016.02.011
  15. Zhu W, Buffa JA, Wang Z, Warrier M, Schugar R, Shih DM, Gupta N, Gregory JC, Org E, Fu E, Li L, DiDonato JA, Lusis AJ, Brown JM, Hazen SL. Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk. Journal of Thrombosis and Haemostasis. 2018;16:9:1857-1872. https://doi.org/10.1111/jth.14234
  16. Bogiatzi C, Gloor G, Allen-Vercoe E, Reid G, Wong RG, Urquhart BL, Dinculescu V, Ruetz KN, Velenosi TJ, Pignanelli M, Spence JD. Metabolic products of the intestinal microbiome and extremes of atherosclerosis. Atherosclerosis. 2018;273:91-97. https://doi.org/10.1016/j.atherosclerosis.2018.04.015
  17. Organ CL, Otsuka H, Bhushan S, Wang Z, Bradley J, Trivedi R, Polhemus DJ, Tang WHW, Wu Y, Hazen SL, Lefer DJ. Choline Diet and Its Gut Microbe-Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload-Induced Heart Failure. Clinical perspective. Circulation: Heart Failure. 2015;9(1):e002314. https://doi.org/10.1161/circheartfailure.115.00231
  18. Tang WHW, Wang Z, Fan Y, Levison B, Hazen JE, Donahue LM, Wu Y, Hazen SL. Prognostic Value of Elevated Levels of Intestinal Microbe-Generated Metabolite Trimethylamine N-Oxide in Patients With Heart Failure. Journal of the American College of Cardiology. 2014;64(18):1908-1914. https://doi.org/10.1016/j.jacc.2014.02.617
  19. Heianza Y, Ma W, Manson JE, Rexrode KM, Qi L. Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective Studies. Journal of the American Heart Association. 2017;6(7):e004947. https://doi.org/10.1161/jaha.116.004947
  20. Grabowska-Polanowska B, Faber J, Skowron M, Miarka P, Pietrzycka A, Śliwka I, Amann A. Detection of potential chronic kidney disease markers in breath using gas chromatography with mass-spectral detection coupled with thermal desorption method. Journal of Chromatography A. 2013;1301:179-189. https://doi.org/10.1016/j.chroma.2013.05.012
  21. Grabowska-Polanowska B, Skowron M, Miarka P, Pietrzycka A, Śliwka I. The application of chromatographic breath analysis in the search of volatile biomarkers of chronic kidney disease and coexisting type 2 diabetes mellitus. Journal of Chromatography B. 2017;1060:103-110. https://doi.org/10.1016/j.jchromb.2017.05.030

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.